To manage stress, try simple techniques like walking, meditating, or deep breathing
CMS has not released an estimate of how many beneficiaries could be eligible for the Medicare GLP-1 Bridge, although the director of Medicare at CMS, Chris Klomp, recently stated the agency anticipates the program will start with single-digit millions of beneficiaries
Tirzepatide (15mg, Zepbound): Up to 22.5% body weight reduction over 72 weeks in the SURMOUNT trials
After heading to Nooms site, youre dropped into a very long, detailed intake quiz covering multiple categories
We can provide you with an estimate during your consultation
[3][4] Phase 2 clinical trials demonstrated a safety profile generally consistent with the GLP-1/GIP/glucagon agonist class, with no unexpected safety signals during the 48-week study period